SCHEMBL22040032

SCHEMBL22040032

COc1ccc(CC(C)C(C)Cc2ccc(O)c(O)c2)cc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 7/20 1.00
▸ ALOX12 P18054 7/20 1.00
▸ FOS P01100 2/20 0.76
▸ TTR P02766 2/20 0.76
▸ JUN P05412 2/20 0.76
▸ NR3C1 P04150 2/20 0.76
▸ HSD17B1 P14061 2/20 0.76
▸ HSD17B2 P37059 2/20 0.76
▸ CYP3A4 P08684 3/20 0.71
▸ KDM4E B2RXH2 2/20 0.71
▸ MEN1 O00255 2/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ ESR1 P03372 2/20 0.71
▸ TP53 P04637 2/20 0.71
▸ HPGD P15428 2/20 0.71
▸ MAPK1 P28482 2/20 0.71
▸ RECQL P46063 2/20 0.71
▸ KMT2A Q03164 2/20 0.71
▸ HIF1A Q16665 2/20 0.71
▸ HSD17B10 Q99714 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29794171 0.92 ALOX15 (1.00) ALOX15ALOX12FOSTTRJUN
SCHEMBL29929344 0.92 ALOX15 (1.00) ALOX15ALOX12FOSTTRJUN
SCHEMBL13309003 0.92 ALOX15 (1.00) ALOX15ALOX12FOSTTRJUN
SCHEMBL4639890 0.92 ALOX15 (1.00) ALOX15ALOX12FOSTTRJUN
SCHEMBL2390 0.92 FOS (0.90) ALOX15ALOX12FOSTTRJUN
SCHEMBL16917560 0.92 FOS (0.90) ALOX15ALOX12FOSTTRJUN
SCHEMBL3160 0.92 ALOX15 (0.90) ALOX15ALOX12FOSTTRJUN
SCHEMBL4640898 0.92 ALOX15 (0.90) ALOX15ALOX12FOSTTRJUN
SCHEMBL31237435 0.92 FOS (0.90) ALOX15ALOX12FOSTTRJUN
Terameprocol SCHEMBL2356280 0.88 ALOX15 (0.77) ALOX15ALOX12FOSTTRJUN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744820-B2 Inhibitors of microbially induced amyloid AXIAL THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
US-11744820-B2 Inhibitors of microbially induced amyloid AXIAL THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
US-11147792-B2 Inhibitors of microbially induced amyloid AXIAL THERAPEUTICS, INC. (US) 2021-10-19 — — US disclosed
US-20200163933-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL BIOTHERAPEUTICS, INC. 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744820-B2 Inhibitors of microbially induced amyloid APP, PSEN1, BACE1 ALOX15 684/4885ALOX12 726/4885FOS 799/4885
US-20200163933-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID APP, PSEN1, BACE1 ALOX15 684/4885ALOX12 726/4885FOS 799/4885
US-11147792-B2 Inhibitors of microbially induced amyloid APP, PSEN1, BACE1 ALOX15 684/4885ALOX12 726/4885FOS 799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback